Over the past 14 years The Schistosomiasis Control Initiative (SCI) at Imperial College London, have made it their mission to support the control and elimination of schistosomiasis.

Around a billion people suffer from neglected tropical diseases, with schistosomiasis being the most deadly, yet many of us have never heard of them. Without treatment, NTDs lead to lifelong disabilities and suffering. Treating them is necessary to ensure that efforts to aid nutrition, education, health and economic productivity are successful. Controlling and eliminating NTDs is vital if we are to end extreme poverty.

Since they were founded, SCI has supported the delivery of over 120 million treatments against schistosomiasis. All medicines are donated by pharmaceutical companies. SCI ensure they are distributed where they are most needed and their impact is monitored. As part of an academic institution SCI also carries out operational research to ensure that the strategies used are based on strong science.

It costs just £1 to treat three children or at risk adults making these programmes one of the most cost-effective health interventions available.

Their work is regularly recommended by Givewell, Giving What We Can and The Life You Can Save and they have recently been awarded an A+ rating from the UK government’s Department for International Development.

We’re proud to have partnered with SCI for the past five years, and have funded treatments for 37,415 people. This month we are fundraising to treat 15,000 more.

Join us this month and help us reach our target! Every £1 donated will treat 3 children and at-risk adults.